Adenoid Cystic Carcinoma clinical trials

Explore recruiting adenoid cystic carcinoma clinical trials.

Recruiting adenoid cystic carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adenoid Cystic Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The evaluation of the effectiveness, safety and tolerability of treatment, using a specialized prostate-specific membrane antigen (PSMA) labeled with Lutetium177, in patients with recurrent and/or metastatic adenoid cystic carcinoma originating from the salivary glands - an open, non-commercial clinical trial

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1, multicenter, open-label study of REM-422, a MYB mRNA degrader, in patients with recurrent or metastatic, adenoid cystic carcinoma.

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic Carninoma of the Head and Neck

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase III randomized trial comparating concomittant administration of radiotherapy with cisplatin versus radiotherapy only for treatment of sinuses tumors and salivary glands (SANTAL)

Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study of SGN-B7H4V in Advanced Solid Tumors

France, Spain, Italy, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers

Italy, Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Adenoid Cystic Carcinoma trials by city

Adenoid Cystic Carcinoma in Toronto Adenoid Cystic Carcinoma in Vancouver Adenoid Cystic Carcinoma in Montreal Adenoid Cystic Carcinoma in Calgary Adenoid Cystic Carcinoma in Edmonton Adenoid Cystic Carcinoma in Ottawa Adenoid Cystic Carcinoma in Winnipeg Adenoid Cystic Carcinoma in Quebec City Adenoid Cystic Carcinoma in Hamilton Adenoid Cystic Carcinoma in Kitchener Adenoid Cystic Carcinoma in London Adenoid Cystic Carcinoma in Halifax Adenoid Cystic Carcinoma in New York Adenoid Cystic Carcinoma in Los Angeles Adenoid Cystic Carcinoma in Chicago Adenoid Cystic Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease